Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tolmar is a fully integrated specialty pharmaceutical company focused on the development, manufacturing, and commercialization of innovative therapeutic solutions in urology, oncology, and dermatology. The company is best known for its proprietary ATRIGEL Delivery System, a biodegradable polymer-based technology that enables the sustained release of therapeutic agents over extended periods. Tolmar's flagship product, ELIGARD (leuprolide acetate), is a leading treatment for advanced prostate cancer. Headquartered in the United States, the company maintains significant research, development, and state-of-the-art manufacturing facilities to support its global commercial operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tolmar Therapeutics.